Product Information
BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Padagis US LLC, priced at $10.0787 per ML under NDC 00574401215. Its NADAC has been published 141 times since Dec 13, 2023.
FDA first approved this application on Jul 28, 2023.
Strength
10 mg/mL
Manufacturer
Padagis US LLCNDC
00574401215
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BRINZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211914FDA Approved
7/28/2023
On Market Since
10/10/2023
Pharmacological Classes
Price Statistics
The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 141 times since Dec 13, 2023, and over the history we have for it it has declined 38.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0787 per ML |
|---|---|
| All-time high | $17.2178 (Mar 12, 2025) |
| All-time low | $7.2636 (May 22, 2024) |
| 52-week high | $14.3013 |
| 52-week low | $10.0787 |
| Median price | $12.4233 |
| Average price | $12.2953 |
| Largest weekly change | -39.2% (May 22, 2024) |
| Weeks tracked | 141 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Padagis US LLC, is $10.0787 per ML (NDC 00574401215), effective Aug 19, 2026.
How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 38.8%. It has been tracked across 141 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?
Since Dec 13, 2023, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $7.2636 (May 22, 2024) to a high of $17.2178 (Mar 12, 2025), with a median of $12.4233 per ML.
Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $9.4893 per ML — about 6% below BRINZOLAMIDE 1% EYE DROPS.
Who manufactures BRINZOLAMIDE 1% EYE DROPS?
BRINZOLAMIDE 1% EYE DROPS (NDC 00574401215) is labeled by Padagis US LLC, and CMS classifies it as a generic product.